Search All News
With a new three-year, $775,000 Translational Research Program grant by The Leukemia & Lymphoma Society, Dr. Lentzsch and collaborators unveil a promising new approach to treat multiple myeloma.
March is Multiple Myeloma Awareness month, and in this Q+A, Dr. Rajshekhar Chakraborty takes us through where we are today in multiple myeloma research and treatment.
Dr. Suzanne Lentzsch and her team have recently identified a promising new drug target in a subset of multiple myeloma cases, those with RAS mutations. The research was published in the journal Blood.
Rajshekhar Chakraborty, MD, and Shawn Sarkaria, MD, two new faculty members at Columbia University Irving Medical Center, have joined the Multiple Myeloma Center.
- February 24, 2020
A new clinical trial for AL amyloidosis is paving the way for a promising new treatment option for patients with the rare organ-debilitating disease.